ENTOS

Live / Registered — Registered (as of 19 Nov 2024)

What this means for you

Registered since 19 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97978410
Registration number
7568415
Mark type
Design + words
Filed
14 Sept 2022
Published for opposition
03 Sept 2024
Registered
19 Nov 2024
Attorney of record
Theodore R. Remaklus

Goods and services

  • Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies for others; custom manufacturing of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies
  • Class 042 — Scientific and technological services: Advisory services relating to gene therapy research; research in the field of gene therapy; research and development of vaccines and medicines; information on the subject of scientific research in the field of biotechnology; genetic testing for scientific research purposes; scientific research in the field of genetics and genetic engineering; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the field of therapeutic and diagnostic products; scientific research, pharmaceutical research, medical research, technical consultation in the field of pharmaceutical studies and product development for others in the field of biotechnology and product development of pharmaceuticals, therapeutic agents and medical devices; research and product development in the field of human vaccines, recombinant proteins and antibodies for therapeutic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccines, therapeutic proteins and antibodies; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticals, pharmaceutical ingredients, human vaccines, therapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates
  • Class 044 — Medical, beauty and agricultural services: Medical therapy services, namely gene therapy services; medical analysis services, namely RNA or DNA analysis for virus diagnosis and prognosis; medical information services, namely, providing information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; on-line information services, namely, providing medical information to physicians, healthcare professionals and patients on the topics of health issues that can be treated with vaccines, recombinant proteins and antibodies, diagnostic, prophylactic and therapeutic properties of vaccines, recombinant proteins and antibodies; genetic testing for medical purpose

Owner

Prosecution history

  • 04 Jan 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
  • 04 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 04 Jan 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 04 Jan 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 04 Jan 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
  • 04 Jan 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
  • 19 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 19 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
  • 03 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 03 Sept 2024 — PUBLISHED FOR OPPOSITION
  • 14 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 25 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 25 Jun 2024 — DIVISIONAL PROCESSING COMPLETE
  • 16 Nov 2023 — DIVISIONAL REQUEST RECEIVED
  • 12 Jun 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL

View this trademark record on Marksy